AUPN727595A0 - Therapeutic compositions - Google Patents

Therapeutic compositions

Info

Publication number
AUPN727595A0
AUPN727595A0 AUPN7275A AUPN727595A AUPN727595A0 AU PN727595 A0 AUPN727595 A0 AU PN727595A0 AU PN7275 A AUPN7275 A AU PN7275A AU PN727595 A AUPN727595 A AU PN727595A AU PN727595 A0 AUPN727595 A0 AU PN727595A0
Authority
AU
Australia
Prior art keywords
therapeutic compositions
therapeutic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN7275A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Walter and Eliza Hall Institute of Medical Research
Original Assignee
Walter and Eliza Hall Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter and Eliza Hall Institute of Medical Research filed Critical Walter and Eliza Hall Institute of Medical Research
Priority to AUPN7275A priority Critical patent/AUPN727595A0/en
Publication of AUPN727595A0 publication Critical patent/AUPN727595A0/en
Priority to EP96941537A priority patent/EP0868430A4/en
Priority to CA002241129A priority patent/CA2241129A1/en
Priority to PCT/AU1996/000827 priority patent/WO1997023501A1/en
Priority to JP9523157A priority patent/JP2000504932A/en
Priority to AU10891/97A priority patent/AU710221B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4747—Apoptosis related proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AUPN7275A 1995-12-22 1995-12-22 Therapeutic compositions Abandoned AUPN727595A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
AUPN7275A AUPN727595A0 (en) 1995-12-22 1995-12-22 Therapeutic compositions
EP96941537A EP0868430A4 (en) 1995-12-22 1996-12-20 Therapeutic compositions
CA002241129A CA2241129A1 (en) 1995-12-22 1996-12-20 Therapeutic compositions
PCT/AU1996/000827 WO1997023501A1 (en) 1995-12-22 1996-12-20 Therapeutic compositions
JP9523157A JP2000504932A (en) 1995-12-22 1996-12-20 Therapeutic composition
AU10891/97A AU710221B2 (en) 1995-12-22 1996-12-20 Therapeutic compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN7275A AUPN727595A0 (en) 1995-12-22 1995-12-22 Therapeutic compositions

Publications (1)

Publication Number Publication Date
AUPN727595A0 true AUPN727595A0 (en) 1996-01-18

Family

ID=3791594

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPN7275A Abandoned AUPN727595A0 (en) 1995-12-22 1995-12-22 Therapeutic compositions
AU10891/97A Ceased AU710221B2 (en) 1995-12-22 1996-12-20 Therapeutic compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU10891/97A Ceased AU710221B2 (en) 1995-12-22 1996-12-20 Therapeutic compositions

Country Status (5)

Country Link
EP (1) EP0868430A4 (en)
JP (1) JP2000504932A (en)
AU (2) AUPN727595A0 (en)
CA (1) CA2241129A1 (en)
WO (1) WO1997023501A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6156535A (en) * 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods
AU753027B2 (en) 1998-02-11 2002-10-03 Genvec, Inc. Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
DE60327618D1 (en) 2002-03-27 2009-06-25 Aegera Therapeutics Inc ANTISENSE NUCLEOBASIS AND ITS APPLICATIONS AGAINST IAP
US8012944B2 (en) 2003-10-30 2011-09-06 Pharmascience Inc. Method for treating cancer using IAP antisense oligomer and chemotherapeutic agent
TWI504597B (en) * 2006-03-16 2015-10-21 Pharmascience Inc Iap bir domain binding compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08500482A (en) * 1992-06-12 1996-01-23 マサチューセッツ インスティテュート オブ テクノロジー Inhibitors of Ced-3 and related proteins
US5646008A (en) * 1993-06-22 1997-07-08 The Regent Of The University Of Michigan Vertebrate apoptosis gene: compositions and methods
JPH08511690A (en) * 1993-06-24 1996-12-10 ザ・ジェネラル・ホスピタル・コーポレーション Programmed cell death genes and proteins
EP0830375A4 (en) * 1995-05-11 2001-11-21 Human Genome Sciences Inc Human inhibitor of apoptosis gene 1
US6156535A (en) * 1995-08-04 2000-12-05 University Of Ottawa Mammalian IAP gene family, primers, probes, and detection methods

Also Published As

Publication number Publication date
WO1997023501A1 (en) 1997-07-03
EP0868430A1 (en) 1998-10-07
AU710221B2 (en) 1999-09-16
EP0868430A4 (en) 2002-08-07
JP2000504932A (en) 2000-04-25
CA2241129A1 (en) 1997-07-03
AU1089197A (en) 1997-07-17

Similar Documents

Publication Publication Date Title
AU6513298A (en) Therapeutic compositions
AU6216296A (en) Pharmaceutical compositions
AU6374896A (en) Cable-sheathing composition
AUPN411195A0 (en) Medicinal composition
AU6725496A (en) Peroxidase-activating oral compositions
AU4928396A (en) Oral compositions
AU5060796A (en) Composition
AU7590096A (en) Drug composition
AU7439696A (en) Fluoride-releasing compositions
AU7265596A (en) Probiotically acting formulations
AU5155096A (en) Pharmaceutical composition
AU5560596A (en) Formed compositions
AU5274096A (en) Pharmaceutical compositions
AU4756996A (en) Oral compositions
AU3460897A (en) Medicinal compositions
AU1129697A (en) Modified polyalkadiene-containing compositions
AU2547895A (en) Therapeutic phenoxyalkylheterocycles
AUPN727595A0 (en) Therapeutic compositions
AU6619596A (en) Compositions
AU7190496A (en) Therapeutic compositions
AU7641098A (en) Therapeutic composition
AU679162B3 (en) Therapeutic compositions
AU1427895A (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
AU7289396A (en) Cosmetic compositions